Thyrocare Technologies Limited (THYROCARE) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.238x

Based on the latest financial reports, Thyrocare Technologies Limited (THYROCARE) has a cash flow conversion efficiency ratio of 0.238x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.27 Billion ≈ $13.75 Million USD) by net assets (Rs5.34 Billion ≈ $57.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Thyrocare Technologies Limited (THYROCARE) defensive interval to measure how many days the company can operate on defensive assets alone.

Thyrocare Technologies Limited - Cash Flow Conversion Efficiency Trend (2011–2026)

This chart illustrates how Thyrocare Technologies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Thyrocare Technologies Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Thyrocare Technologies Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Guangdong Hongtu Technology Holdings Co Ltd SHE:002101	0.023x
Sparebanken Sor OL:SOR	0.095x
Arafura Rare EARTHS Ltd AU:ARU	-0.014x
HMT Limited NSE:HMT	-0.004x
Matrix Design Co. Ltd. A SHE:301365	N/A
Hartalega Holdings Bhd KLSE:5168	0.029x
Shenyang Blue Silver Ind Auto SHE:300293	-0.053x
Navigator Global Investments Ltd AU:NGI	0.054x

Annual Cash Flow Conversion Efficiency for Thyrocare Technologies Limited (2011–2026)

The table below shows the annual cash flow conversion efficiency of Thyrocare Technologies Limited from 2011 to 2026. For the full company profile with market capitalisation and key ratios, see Thyrocare Technologies Limited market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs5.86 Billion ≈ $63.38 Million	Rs2.16 Billion ≈ $23.39 Million	0.369x	+5.54%
2025-03-31	Rs5.47 Billion ≈ $59.16 Million	Rs1.91 Billion ≈ $20.69 Million	0.350x	+10.08%
2024-03-31	Rs5.28 Billion ≈ $57.06 Million	Rs1.68 Billion ≈ $18.13 Million	0.318x	+31.50%
2023-03-31	Rs5.35 Billion ≈ $57.88 Million	Rs1.29 Billion ≈ $13.98 Million	0.242x	+12.18%
2022-03-31	Rs5.27 Billion ≈ $56.95 Million	Rs1.13 Billion ≈ $12.26 Million	0.215x	-20.69%
2021-03-31	Rs4.27 Billion ≈ $46.21 Million	Rs1.16 Billion ≈ $12.55 Million	0.272x	-40.60%
2020-03-31	Rs3.67 Billion ≈ $39.65 Million	Rs1.68 Billion ≈ $18.13 Million	0.457x	+98.31%
2019-03-31	Rs4.35 Billion ≈ $47.06 Million	Rs1.00 Billion ≈ $10.85 Million	0.231x	-4.52%
2018-03-31	Rs4.43 Billion ≈ $47.94 Million	Rs1.07 Billion ≈ $11.57 Million	0.241x	+9.81%
2017-03-31	Rs4.07 Billion ≈ $43.99 Million	Rs894.44 Million ≈ $9.67 Million	0.220x	+18.57%
2016-03-31	Rs3.66 Billion ≈ $39.54 Million	Rs678.01 Million ≈ $7.33 Million	0.185x	+67.15%
2015-03-31	Rs3.11 Billion ≈ $33.60 Million	Rs344.68 Million ≈ $3.73 Million	0.111x	-50.51%
2014-03-31	Rs2.06 Billion ≈ $22.31 Million	Rs462.39 Million ≈ $5.00 Million	0.224x	-21.84%
2013-03-31	Rs1.60 Billion ≈ $17.31 Million	Rs459.23 Million ≈ $4.97 Million	0.287x	-28.11%
2012-03-31	Rs1.02 Billion ≈ $11.08 Million	Rs408.87 Million ≈ $4.42 Million	0.399x	-16.85%
2011-03-31	Rs675.33 Million ≈ $7.30 Million	Rs324.07 Million ≈ $3.50 Million	0.480x	--

About Thyrocare Technologies Limited

NSE:THYROCARE India Diagnostics & Research

Market Cap

$890.24 Million

Rs82.32 Billion INR

Market Cap Rank

#9480 Global

#467 in India

Share Price

Rs517.20

Change (1 day)

-6.94%

52-Week Range

Rs349.55 - Rs1591.90

All Time High

Rs1591.90